Wolverine Trading’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$250K Buy
5,200
+1,000
+24% +$61.9K ﹤0.01% 4642
2025
Q2
$310K Sell
4,200
-400
-9% -$26.5K ﹤0.01% 3447
2025
Q1
$291K Sell
4,600
-3,200
-41% -$218K ﹤0.01% 3566
2024
Q4
$597K Buy
7,800
+4,900
+169% +$394K ﹤0.01% 3195
2024
Q3
$231K Buy
+2,900
New +$234K ﹤0.01% 3914
2024
Q1
Sell
-11,200
Closed -$958K 4778
2023
Q4
$958K Buy
+11,200
New +$968K ﹤0.01% 2346
2023
Q3
Sell
-2,500
Closed -$212K 4731
2023
Q2
$212K Sell
2,500
-1,900
-43% -$161K ﹤0.01% 3467
2023
Q1
$353K Buy
+4,400
New +$356K ﹤0.01% 2853
2022
Q1
Sell
-5,000
Closed -$268K 5797
2021
Q4
$268K Buy
+5,000
New +$305K ﹤0.01% 4309
2021
Q3
Sell
-20,300
Closed -$1.35M 6517
2021
Q2
$1.35M Buy
+20,300
New +$1.44M ﹤0.01% 2437
2020
Q4
Sell
-7,600
Closed -$660K 5048
2020
Q3
$660K Buy
7,600
+500
+7% +$43.7K ﹤0.01% 2513
2020
Q2
$625K Buy
+7,100
New +$717K ﹤0.01% 2498
2018
Q4
Sell
-3,600
Closed -$412K 4782
2018
Q3
$412K Buy
+3,600
New +$373K ﹤0.01% 3340

Other funds holding HAE

Wolverine Trading's HAE Position: Q2 2025 in Review

Wolverine Trading sold out of Haemonetics (HAE) in Q2 2025, closing a stake of 3,573 shares — an estimated $237K sold.

Wolverine Trading first reported a position in HAE in Q1 2018 and held it in 9 quarters. The position peaked at $1.14M in Q2 2021. 298 funds tracked by Wall St. Rank hold HAE as of Q2 2025.

  • Wolverine Trading reported no remaining Haemonetics position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 3,573 Haemonetics shares in Q2 2025, an estimated $237K.
  • Wolverine Trading first reported a position in Haemonetics in Q1 2018 and held it in 9 quarters.
  • Wolverine Trading's Haemonetics position peaked at $1.14M in Q2 2021.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.